Medical supply issues continue to trouble NHS reform watchdogs
This article was originally published in Clinica
Key issues affecting the UK’s medical supplies industry continue to worry parliamentarians overseeing the government’s reforms of the NHS, an urgently-convened meeting of the health select committee (HSC) revealed today.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.